Interrogation > Brevets > Anglais
PCT Yearly Review 2012
The International Patent System
Comprehensive facts, figures and analysis of the international patent system. Special theme: two million PCT filings
Année de publication: 2012
The International Patent System in 2010
PCT Yearly Review
Comprehensive facts, figures and analysis of the international patent system. Special theme: the changing geography of the PCT system
Année de publication: 2011
Technology and Innovation Support Centers (TISCs) - Enhancing innovation through knowledge and expertise
Technology and Innovation Support Centers (TISCs) are designed to provide innovators in developing countries with access to locally based, high quality technology information services and other related services.
Guide to the International Patent Classification (2011)
WIPO Survey on Patenting Strategies in 2009 and 2010 - Final report
To better understand how users of the PCT System responded to the difficult economic conditions in 2009 and how they may respond to the incipient economic recovery in 2010.
The State of Patenting at Research Institutions in Developing Countries: Policy Approaches and Practices
Economic Research Working Paper No. 4
This study discusses the opportunities and challenges offered by patents to foster technology transfer from government funded research institutions in developing countries. It presents a review of policy frameworks and recent policy changes aimed to foster academic patenting and technology transfer in low- and middle-income countries. It then analyzes patenting activities by universities and public research organizations and compares these trends with respect to high-income countries. This analysis is complemented with an assessment of the current state of patenting and technology commercialization practices in a selected group of technology transfer offices.
Patent Landscape Report on Atazanavir
This patent landscape report is dedicated to Atazanavir – an antiretroviral drug used to treat HIV infection and AIDS. A major objective of this report is to examine the evolution of the patent environment protecting Atazanavir from the first filing of this compound to the present filings. The second objective is to provide insight into best practice for probing the patent literature in the pharmaceutical area. Because combination therapies involving more than one drug are such an integral part of pharmaceutical development, and because that is especially true for AIDS therapies, a separate chapter of the report focuses on combinations.
Patent Landscape Report on Solar Cooking
This patent landscape report seeks to provide a comprehensive overview of available technologies that exclusively use solar energy as the primary energy source for cooking or pasteurizing food. At the same time it identifies systems that are simple and easy to use in environments of rural communities; preferably systems that could be used in individual households. The report provides a description of the patent search methodology and evaluation of the results, showcasing the tools for accessing and using patent information. It clusters the available technologies in four categories based on the main heating methods used.
Patent Landscape Report on Desalination Technologies and the Use of Alternative Energies for Desalination
This report identified 4551 patent families (including utility models) that claim inventions related to desalination of water, and 921 families describing the combination of desalination technologies with the use of renewable energies. Based on this patent collection, various patterns of patenting activity and innovation in the area of desalination are presented, with a separate focus on the use of renewable energies for desalination. A comprehensive explanation of the search methodology and history (including all search queries), and of the evaluation of the search results is included and illustrates how patent information can be retrieved and exploited in the area of desalination.
Patent Landscape Report on Ritonavir
This report is dedicated to Ritonavir – an antiretroviral drug used to treat HIV infection and AIDS. A major goal of the report is to highlight the technology timeline for Ritonavir from the first filing of this compound to the present filings. It identifies a number of innovation tracks derived from the first Ritonavir patent document. The report also includes an analysis of statistical trends. A comprehensive explanation of the search methodology and history (including all search queries), and of the evaluation of the search results is included and illustrates how patent information can be retrieved and exploited in the area of pharmaceuticals.